WART revisited: The treatment of epithelial ovarian cancer by whole abdominal radiotherapy

Australasian Radiology

Volumn 41, Issue 3, 1997, Pages 276-280

  Hruby, G ^a   Bull, C A ^a   Langlands, A O ^a   Gebski, V ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Epithelial ovarian cancer; Whole abdominal radiotherapy

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; LIVER ENZYME;

ABDOMINAL RADIOTHERAPY; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER RECURRENCE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; SALPINGOOOPHORECTOMY; TRANSFUSION;

EID: 0030743112     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.1997.tb00673.x     Document Type: Article

References (20)

1. Feigen M. Ovarian cancer: A comparison of two techniques for postoperative whole abdominal radiotherapy. Australas. Radiol. 1986; 30: 103-8.
2. Feigen M. Fatal veno-occlusive disease of the liver associated with herbal tea consumption and radiation. Aust. N.Z. J. Med. 1984; 14: 61-2.
3. Dembo AJ. Abdominopelvic radiotherapy in ovarian cancer: A 10-year experience. Cancer 1985; 55: 2285-90.
4. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br. J. Obstet. Gynaecol. 1989; 96: 889-92.
5. Dembo AJ, Bush RS. Choice of postoperative therapy based on prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 1982; 8: 893-7.
6. Martinez A, Schray MF, Howes AE, Bagshaw M. Postoperative radiation therapy for epithelial ovarian cancer: The curative role based on a 24-year experience. J. Clin. Oncol. 1985; 3: 901-11.
7. Fuller DB, Sause WT, Plenk HP, Menlove RL. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J. Clin. Oncol. 1987; 5: 897-905.
8. Dembo AJ. Epithelial ovarian cancer: The role of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1992; 22: 835-45.
9. Carey MS, Dembo AJ, Simm JE et al. Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: A 15-year review. Int. J. Gynecol. Cancer 1993; 3: 24-35.
10. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RM, Kjorstadt K. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet. Gynecol. 1990; 75: 263-72.
11. Fyles AW, Dembo AJ, Bush RS et al. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1992; 22: 847-51.
12. Schray MF, Martinez A, Howes AE. Toxicity of open-field whole abdominal irradiation as primary postoperative treatment in gynecologic malignancy. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16: 397-403.
13. van Bunningen B, Bouma J, Kooijman C, Warlam-Rodenhuis CC, Heintz APM, van Lindert A. Total abdominal irradiation in stage I and II carcinoma of the ovary. Radiother. Oncol. 1988; 11: 305-10.
14. Whelan TJ, Dembo AJ, Bush RS et al. Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Int. J. Radiat. Oncol. Biol. Phys. 1992; 22: 853-8.
15. Fazekas JT, Maier JG. Irradiation of ovarian carcinomas: A prospective comparison of the open-field and moving-strip techniques. AJR 1974; 120: 118-23.
16. Dembo AJ, Bush RS, Beale FA et al. A randomized clinical trial of moving strip vs open field whole abdominal irradiation in patients with invasive epithelial cancer of the ovary. Int. J. Radiat. Oncol. Biol. Phys. 1983; 9 (Suppl.): 97.
17. Wils J, van Geuns H. Chemotherapy consisting of cisplatin, doxoxrubicin, and cyclophosphamide as an adjunct to surgery in stage IC-II epithelial ovarian carcinoma. Am. J. Clin. Oncol. 1989; 12: 251-4.
18. Piver MS, Malfetano J, Hempling RE, Baker TR, Driscoll DL. Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: A preliminary report. Gynecol. Oncol. 1990; 39: 249-52.
19. Neijt JP, ten Bokkel Huinink WW, van der Burg MEL et al. Long-term survival in ovarian cancer. Eur. J. Cancer 1991; 27: 1367-72.
20. Vergote IB, Vergote-De Vos LN, Abeler VM et al. Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer. Cancer 1992; 69: 741-9.